Miromatrix Submits Pre-IND Request to the FDA for Its External Liver Assist Product to Treat Acute Liver Failure
December 17, 2021 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Reports Third Quarter 2021 Results
November 15, 2021 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix to Report Third Quarter 2021 Financial Results
October 28, 2021 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Animal
October 07, 2021 05:30 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Medical Added to Russell Microcap® Index
September 20, 2021 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development
September 09, 2021 08:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys
August 11, 2021 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Medical Announces Closing of Initial Public Offering
June 28, 2021 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., June 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering a novel technology for bioengineering fully...
Miromatrix Medical Announces Pricing of Upsized Initial Public Offering
June 24, 2021 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) ("Miromatrix"), a life sciences company pioneering a novel technology for bioengineering fully...